首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen.
【24h】

Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen.

机译:气管内递送同种异体抗原后免疫抑制剂对调节细胞诱导的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: We previously reported that intratracheal delivery (ITD) of alloantigen generated regulatory cells in mice. Here, we examined the effect of various doses of conventional immunosuppressants (FK506, cyclosporine A, azathioprine, mycophenolate mofetil, and rapamycin) on inducing regulatory cells in our model. METHODS: CBA mice (primary recipients) were given C57BL/6 splenocytes by ITD and either no additional treatment or various doses of an immunosuppressant. Seven days later, splenocytes from these mice were adoptively transferred into naive secondary CBA recipients that underwent C57BL/6 cardiac grafting the same day. RESULTS: Adoptive transfer from primary recipients given ITD of splenocytes alone induced prolonged allograft survival in secondary recipients (median survival time [MST], 50 days), suggesting that regulatory cells were generated. When ITD of alloantigen was combined with daily administration of 0.1 mg/kg FK506 or 0.2 mg/kg rapamycin, graft survival was similarly prolonged (MST 55 and 50 days, respectively). When combined with 20 or 40 mg/kg MMF or 0.4 mg/kg rapamycin, the majority of recipients demonstrated indefinite survival (MST, >100 days in all groups). When ITD of alloantigen was combined with 0.3, 0.5, or 1.0 mg/kg FK506; 5, 10, or 25 mg/kg cyclosporine A; or 1.0 or 2.0 mg/kg azathioprine, allografts were rejected acutely (MST 7-13 days). CONCLUSION: Generation of regulatory cells by ITD of alloantigen was facilitated by mycophenolate mofetil and high doses of rapamycin but abrogated by cyclosporine A, azathioprine, and high doses of FK506. Low doses of rapamycin and of FK506 did not interfere with generation of regulatory cells.
机译:背景:我们以前曾报道,同种抗原的气管内递送(ITD)在小鼠中产生调节细胞。在这里,我们检查了各种剂量的常规免疫抑制剂(FK506,环孢素A,硫唑嘌呤,霉酚酸酯和雷帕霉素)对我们模型中调控细胞的诱导作用。方法:ITA给CBA小鼠(主要受体)提供C57BL / 6脾细胞,不进行其他治疗或使用不同剂量的免疫抑制剂。 7天后,将来自这些小鼠的脾细胞过继转移到幼稚的次要CBA接受者中,该接受者当天接受了C57BL / 6心脏移植。结果:仅接受脾脏ITD的主要受体的过继转移导致了次要受体的同种异体移植物存活时间延长(中位存活时间[MST]为50天),表明产生了调节细胞。当将同种异体抗原的ITD与每日给药0.1 mg / kg FK506或0.2 mg / kg雷帕霉素组合时,移植物的存活率同样得到了延长(分别为MST 55天和50天)。当与20或40 mg / kg MMF或0.4 mg / kg雷帕霉素合用时,大多数接受者表现出无限的生存期(MST,所有组> 100天)。当同种异体抗原的ITD与0.3、0.5或1.0 mg / kg FK506结合时; 5、10或25 mg / kg环孢素A;或1.0或2.0 mg / kg硫唑嘌呤,同种异体移植被急性排斥(MST 7-13天)。结论:霉酚酸酯和高剂量雷帕霉素可促进同种异体抗原ITD调节细胞的产生,而环孢霉素A,硫唑嘌呤和高剂量FK506则可消除这种调节细胞。小剂量雷帕霉素和FK506不会干扰调节细胞的产生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号